Lexington biotech plots $86M IPO as key gene therapy trial nears – Boston Business Journal

Posted: September 2, 2017 at 5:47 am


FierceBiotech
Lexington biotech plots $86M IPO as key gene therapy trial nears
Boston Business Journal
A Lexington biotech developing gene therapy treatments for rare eye diseases has announced plans to raise up to $86 million in an initial public offering. Nightstar Therapeutics, a 23-employee company with a 3,300 square foot office in Lexington and a ...
Nightstar files for $86M IPO to fund gene therapy trialsFierceBiotech

all 14 news articles »

Here is the original post:
Lexington biotech plots $86M IPO as key gene therapy trial nears - Boston Business Journal

Related Posts